今开:0.026 | 昨收:0.01868 |
最高:0.026 | 最低:0.0181 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1648984.0 |
Evofem Biosciences(EVFM)2019-05-07 22:05
$Evofem Biosciences(EVFM)$ 8-K - Current report Filed: 2019-05-07 AccNo: 0001618835-19-000085 Size: 176 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文
Evofem Biosciences(EVFM)2019-05-08 22:05
$Evofem Biosciences(EVFM)$ EFFECT - Notice of Effectiveness Filed: 2019-05-07 AccNo: 9999999995-19-001037 Size: 1 KB 网页链接查看全文
Evofem Biosciences(EVFM)2019-05-07 22:05
$Evofem Biosciences(EVFM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-07 AccNo: 0001618835-19-000084 Size: 6 MB 网页链接查看全文
Evofem Biosciences(EVFM)2019-05-08 09:40
$Evofem Biosciences(EVFM)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-05-07 AccNo: 0001618835-19-000088 Size: 288 KB 网页链接查看全文
Guoran2018-05-30 11:13
$Evofem Biosciences, Inc.(EVFM)$ $Neothetics, Inc. (NEOT)$ 前者本来是一家私人公司,借后者的壳上市。主要关注女性生殖系统商业机会。在研产品Amphora避孕凝胶,已到3期临床;预防衣原体和淋病,临床2期。公司不久以4.7的价格发股票加权证约1000万股,大股东invesco认购了200万。两家公司合并...查看全文
Evofem Biosciences(EVFM)2019-05-02 18:35
$Evofem Biosciences(EVFM)$ 美东时间 2019-05-07 盘前 披露财报,预期EPS -0.45 网页链接查看全文
Evofem Biosciences(EVFM)2019-05-01 09:35
$Evofem Biosciences(EVFM)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-04-30 AccNo: 0001618835-19-000073 Size: 449 KB 网页链接查看全文
Evofem Biosciences(EVFM)2019-04-25 09:10
$Evofem Biosciences(EVFM)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-24 AccNo: 0001618835-19-000068 Size: 1 MB 网页链接查看全文
Evofem Biosciences(EVFM)2019-04-23 09:45
$Evofem Biosciences(EVFM)$ D - Notice of Exempt Offering of Securities Filed: 2019-04-22 AccNo: 0001618835-19-000063 Size: 17 KB 网页链接查看全文
Evofem Biosciences(EVFM)2019-04-19 09:50
$Evofem Biosciences(EVFM)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-04-18 AccNo: 0001193125-19-110809 Size: 47 KB 网页链接查看全文
反贾骗联盟首席2022-07-11 14:34
$Agile Therapeutics(AGRX)$ $Evofem Biosciences(EVFM)$ 这两个标的一起来看,信息比较稀少,需要仔细看IR和SEC的内容,方向了解还比较少,是个新的有潜力的细分方向查看全文
反贾骗联盟首席2022-07-11 14:33
$Evofem Biosciences(EVFM)$ 很有意思的标的,这种凝胶类的产品目前知道的人还少,上市周期还比短,借这次的风波会让更多的人更快的知道,但是这种方案没有解决疾病传播的问题查看全文
格隆汇6月27日丨女性用品公司Evofem(EVFM.US)盘前飙升81.82%,报0.676美元。美国最高法院周五的裁决推翻了具有标志性的《1973年罗诉韦德案》关于堕胎权利受联邦宪法保护的裁决。最高法院认定,联邦宪法没有内容涉及保护堕胎的权益,有关堕胎的法律和规定应... 网页链接
$Evofem Biosciences(EVFM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001618835-22-000166 Act: 34 Size: 10 MB 网页链接
$Evofem Biosciences(EVFM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-217375 Act: 34 Size: 49 KB 网页链接
$Evofem Biosciences(EVFM)$ 8-K Current report, item 3.01 Accession Number: 0001618835-22-000158 Act: 34 Size: 224 KB 网页链接
$Evofem Biosciences(EVFM)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001915967-22-000001 Size: 367 KB 网页链接
$Evofem Biosciences(EVFM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001618835-22-000153 Act: 34 Size: 2 MB 网页链接
$Evofem Biosciences(EVFM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001618835-22-000151 Act: 34 Size: 340 KB 网页链接
$Evofem Biosciences(EVFM)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001618835-22-000142 Act: 34 Size: 281 KB 网页链接
$Evofem Biosciences(EVFM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-196995 Act: 34 Size: 51 KB 网页链接
$Evofem Biosciences(EVFM)$ 8-K Current report, item 8.01 Accession Number: 0001618835-22-000138 Act: 34 Size: 227 KB 网页链接
$Evofem Biosciences(EVFM)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001618835-22-000135 Size: 6 KB 网页链接